• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重症肌无力特定患者队列中的胸腺外恶性肿瘤

Extrathymic malignancies in a defined cohort of patients with myasthenia gravis.

作者信息

Basta I, Pekmezovic T, Peric S, Nikolic A, Rakocevic-Stojanovic V, Stevic Z, Marjanovic I, Lavrnic D

机构信息

Neurology Clinic, Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.

Institute of Epidemiology, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.

出版信息

J Neurol Sci. 2014 Nov 15;346(1-2):80-4. doi: 10.1016/j.jns.2014.07.060. Epub 2014 Aug 6.

DOI:10.1016/j.jns.2014.07.060
PMID:25129207
Abstract

INTRODUCTION

Myasthenia gravis (MG) may be associated with extrathymic malignancies, especially in patients with thymoma.

AIM

To determine the frequency and type of extrathymic malignancies in MG patients from the Belgrade area, and to identify potential risk factors associated with tumors.

PATIENTS AND METHOD

The study comprised 390 patients with MG. Different sociodemographic and clinical variables potentially associated with extrathymic neoplasms were analyzed.

RESULTS

Extrathymic malignancies were present in 42 (10.8%) MG patients - 22 (52.4%) males and 20 (47.6%) females. The most frequently detected were breast (40%) and lung (40%) neoplasms. The tumors appeared with similar frequency before (45.2%) and after the onset of MG (42.9%). Significant predictors for the development of extrathymic malignancies were current age (p = 0.001) and immunoglobulin (IVIg) therapy (p = 0.021). On the other hand, current age (p=0.001), longer MG duration (p = 0.001) and generalized form of MG (p = 0.002) were significant predictors of malignancy occurring after the MG onset.

CONCLUSION

Our study revealed that older MG patients, as well as those with longer duration of the disease, and those who received IVIg therapy had a higher oncogenic risk for the development of extrathymic malignancies.

摘要

引言

重症肌无力(MG)可能与胸腺外恶性肿瘤有关,尤其是胸腺瘤患者。

目的

确定贝尔格莱德地区MG患者胸腺外恶性肿瘤的发生率和类型,并识别与肿瘤相关的潜在危险因素。

患者与方法

该研究纳入了390例MG患者。分析了可能与胸腺外肿瘤相关的不同社会人口统计学和临床变量。

结果

42例(10.8%)MG患者存在胸腺外恶性肿瘤,其中男性22例(52.4%),女性20例(47.6%)。最常检测到的是乳腺肿瘤(40%)和肺部肿瘤(40%)。肿瘤在MG发病前(45.2%)和发病后(42.9%)出现的频率相似。胸腺外恶性肿瘤发生的显著预测因素是当前年龄(p = 0.001)和免疫球蛋白(IVIg)治疗(p = 0.021)。另一方面,当前年龄(p = 0.001)、MG病程较长(p = 0.001)和MG的全身型(p = 0.002)是MG发病后发生恶性肿瘤的显著预测因素。

结论

我们的研究表明,年龄较大的MG患者、病程较长的患者以及接受IVIg治疗的患者发生胸腺外恶性肿瘤的致癌风险较高。

相似文献

1
Extrathymic malignancies in a defined cohort of patients with myasthenia gravis.重症肌无力特定患者队列中的胸腺外恶性肿瘤
J Neurol Sci. 2014 Nov 15;346(1-2):80-4. doi: 10.1016/j.jns.2014.07.060. Epub 2014 Aug 6.
2
Extrathymic malignancies in patients with myasthenia gravis.重症肌无力患者的胸腺外恶性肿瘤
J Neurol Sci. 2005 Oct 15;237(1-2):39-43. doi: 10.1016/j.jns.2005.05.009.
3
Extrathymic malignancies in thymoma patients with and without myasthenia gravis.胸腺瘤患者合并和不合并重症肌无力的胸腺外恶性肿瘤。
J Neurol Sci. 2010 Mar 15;290(1-2):66-9. doi: 10.1016/j.jns.2009.11.006. Epub 2010 Jan 19.
4
Risk of extrathymic cancer in patients with myasthenia gravis in Taiwan: a nationwide population-based study.台湾重症肌无力患者发生胸腺外癌症的风险:一项全国性基于人群的研究。
Eur J Neurol. 2012 May;19(5):746-51. doi: 10.1111/j.1468-1331.2011.03621.x. Epub 2012 Jan 4.
5
Extrathymic tumors in patients with myasthenia gravis: a 35-year retrospective study.重症肌无力患者的胸腺外肿瘤:一项35年的回顾性研究。
Neurologist. 2006 Jan;12(1):53-5. doi: 10.1097/01.nrl.0000195828.36108.c3.
6
Extrathymic malignancy in patients with myasthenia gravis.重症肌无力患者的胸腺外恶性肿瘤。
Eur J Cancer. 1991;27(6):745-7. doi: 10.1016/0277-5379(91)90179-h.
7
Risk factors for tumor occurrence in patients with myasthenia gravis.重症肌无力患者肿瘤发生的危险因素。
J Neurol. 2009 Aug;256(8):1221-7. doi: 10.1007/s00415-009-5091-9. Epub 2009 Mar 29.
8
Excessive risk of cancer and in particular lymphoid malignancy in myasthenia gravis patients: a population-based cohort study.重症肌无力患者癌症风险过高,尤其是淋巴系统恶性肿瘤:一项基于人群的队列研究。
Neuromuscul Disord. 2014 Mar;24(3):245-9. doi: 10.1016/j.nmd.2013.11.007. Epub 2013 Nov 22.
9
Comparative analysis of therapeutic options used for myasthenia gravis.用于重症肌无力的治疗选择的比较分析。
Ann Neurol. 2010 Dec;68(6):797-805. doi: 10.1002/ana.22139.
10
Maintenance IVIg therapy in myasthenia gravis does not affect disease activity.重症肌无力的维持性静脉注射免疫球蛋白治疗不影响疾病活动。
J Neurol Sci. 2014 Mar 15;338(1-2):39-42. doi: 10.1016/j.jns.2013.10.043. Epub 2013 Nov 6.

引用本文的文献

1
Surgical management of suspected paraneoplastic myasthenia gravis in rectal cancer during neoadjuvant immunotherapy: a case report.新辅助免疫治疗期间直肠癌疑似副肿瘤性重症肌无力的外科治疗:一例报告
Front Oncol. 2025 Sep 2;15:1503362. doi: 10.3389/fonc.2025.1503362. eCollection 2025.
2
The Association Between Myasthenia Gravis and Higher Extrathymic Cancer Risk.重症肌无力与胸外癌症高风险之间的关联。
Brain Behav. 2025 Jan;15(1):e70143. doi: 10.1002/brb3.70143.
3
An exploration of causal relationships between nine neurological diseases and the risk of breast cancer: a Mendelian randomization study.
一项基于孟德尔随机化研究的九种神经退行性疾病与乳腺癌风险之间因果关系的探索。
Aging (Albany NY). 2024 Apr 24;16(8):7101-7118. doi: 10.18632/aging.205745.
4
Myasthenia gravis after glioblastoma resection: paraneoplastic syndrome or coincidence? A unique case report and review of the literature.神经胶质瘤切除术后出现重症肌无力:副肿瘤综合征还是巧合?一个独特的病例报告及文献复习。
Acta Neurochir (Wien). 2022 Feb;164(2):423-427. doi: 10.1007/s00701-021-05035-3. Epub 2021 Oct 29.
5
Thymoma appearing 9 years after the resection of squamous cell carcinoma of the lip: A case report of triple primary tumors and literature review.唇部鳞状细胞癌切除术后9年出现胸腺瘤:一例三原发性肿瘤病例报告及文献复习
Oncol Lett. 2019 Sep;18(3):2777-2788. doi: 10.3892/ol.2019.10675. Epub 2019 Jul 26.
6
Myasthenia Gravis and Associated Diseases.重症肌无力及相关疾病
Open Access Maced J Med Sci. 2018 Mar 5;6(3):472-478. doi: 10.3889/oamjms.2018.110. eCollection 2018 Mar 15.
7
Neuromuscular issues in systemic disease.系统性疾病的神经肌肉问题。
Curr Neurol Neurosci Rep. 2015 Jul;15(7):48. doi: 10.1007/s11910-015-0565-x.